Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Klein

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Diabetes Care|November 10, 2017
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 DiabetesNathaniel L Baker, Kelly J Hunt, Danielle R Stevens, et al.
Journal of Diabetes and Its Complications|July 8, 2010
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclassesRichard L Klein, Rickey E Carter, Alicia J Jenkins, et al.
Metabolism: Clinical and Experimental|July 29, 2004
In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetesAlicia J Jenkins, Suzanne R Thorpe, Nathan L Alderson, et al.
Atherosclerosis|July 27, 2014
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective studyArpita Basu, Alicia J Jenkins, Julie A Stoner, et al.
Journal of Diabetes and Its Complications|August 6, 2013
Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trialMadona Azar, Timothy J Lyons, Petar Alaupovic, et al.
Metabolism: Clinical and Experimental|August 5, 2014
Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetesRichard L Klein, Samar M Hammad, Nathaniel L Baker, et al.
Diabetes Care|July 17, 2008
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complicationsMaria F Lopes-Virella, Rickey E Carter, Gregory E Gilbert, et al.
Neuromolecular Medicine|July 9, 2016
Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot StudySamar M Hammad, Nathaniel L Baker, Jad M El Abiad, et al.
The Journal of Biological Chemistry|September 10, 2015
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not GlycosylceramideJahangir Iqbal, Meghan T Walsh, Samar M Hammad, et al.
Journal of Lipid Research|January 19, 2008
Increased methionine sulfoxide content of apoA-I in type 1 diabetesJonathan W C Brock, Alicia J Jenkins, Timothy J Lyons, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Diabetes Care|November 10, 2017
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 DiabetesNathaniel L Baker, Kelly J Hunt, Danielle R Stevens, et al.
Journal of Diabetes and Its Complications|July 8, 2010
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclassesRichard L Klein, Rickey E Carter, Alicia J Jenkins, et al.
Metabolism: Clinical and Experimental|July 29, 2004
In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetesAlicia J Jenkins, Suzanne R Thorpe, Nathan L Alderson, et al.
Atherosclerosis|July 27, 2014
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective studyArpita Basu, Alicia J Jenkins, Julie A Stoner, et al.
Journal of Diabetes and Its Complications|August 6, 2013
Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trialMadona Azar, Timothy J Lyons, Petar Alaupovic, et al.
Metabolism: Clinical and Experimental|August 5, 2014
Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetesRichard L Klein, Samar M Hammad, Nathaniel L Baker, et al.
Diabetes Care|July 17, 2008
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complicationsMaria F Lopes-Virella, Rickey E Carter, Gregory E Gilbert, et al.
Neuromolecular Medicine|July 9, 2016
Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot StudySamar M Hammad, Nathaniel L Baker, Jad M El Abiad, et al.
The Journal of Biological Chemistry|September 10, 2015
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not GlycosylceramideJahangir Iqbal, Meghan T Walsh, Samar M Hammad, et al.
Journal of Lipid Research|January 19, 2008
Increased methionine sulfoxide content of apoA-I in type 1 diabetesJonathan W C Brock, Alicia J Jenkins, Timothy J Lyons, et al.
Pageof 7